𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pain in the head and neck cancer patient: Changes over treatment

✍ Scribed by Keefe, Francis J. ;Manuel, Gerdenio ;Brantley, Alton ;Crisson, James

Publisher
Wiley (John Wiley & Sons)
Year
1986
Weight
747 KB
Volume
8
Category
Article
ISSN
0148-6403

No coin nor oath required. For personal study only.

✦ Synopsis

The incidence, severity, and location of pain was evaluated in 30 head and neck cancer patients prior to treatment after the first phase of their treatment and upon the completion of treatment. The incidence of pain was relatively high (40%-70%) and tended to increase slightly over treatment. Patients having advanced disease (stage III or IV) had a higher incidence of pain. Pain severity ratings were stable over treatment. Pain was located close to tumor or incision sites, and a trend for patients to report a greater number of pain sites over treatment was noted. While medical status variables (disease stage and site) were found to predict pain status after the initial phase of cancer treatment, initial pain measurements were more likely to predict pain status at the completion of treatment.

πŸ“œ SIMILAR VOLUMES

A prospective, longitudinal study of pai
A prospective, longitudinal study of pain in head and neck cancer patients
✍ John M. Chaplin; Randall P. Morton πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 128 KB πŸ‘ 2 views

## Background. Little is known about the epidemiology of pain in head and neck cancer, the effects of curative treatment on this pain, and the impact that pain experience may have on patients' quality of life (QL). Method. The prevalence and severity of pain was studied in 93 patients who were fi

Methylphenidate treatment of patients wi
Methylphenidate treatment of patients with head and neck cancer
✍ Fernandez, Francisco ;Adams, Frank πŸ“‚ Article πŸ“… 2006 πŸ› Wiley (John Wiley & Sons) βš– 491 KB πŸ‘ 2 views

Five organically impaired and depressed head and neck cancer patients had a marked therapeutic response to methylphenidate (MPD). There was a rapid remission of depressive and cognitive dysfunctions without adverse side effects. The relationship of cognitive, behavioral, and affective symptoms to br

Disability and rehabilitation in head an
Disability and rehabilitation in head and neck cancer patients after treatment
✍ Olson, Marian L. ;Shedd, Donald P. πŸ“‚ Article πŸ“… 1978 πŸ› Wiley (John Wiley & Sons) βš– 589 KB

## Abstract In an effort to obtain quantitative and qualitative information regarding the extent of disability sustained following definitive treatment for head and neck cancer, 51 patients–28 who had had laryngectomy and 23 who had had other major surgery–were interviewed. Also examined were the t

Osseointegrated implants in the head and
Osseointegrated implants in the head and neck cancer patient
✍ Michael A. McGhee; Scott J. Stern; Donald Callan; Kristopher Shewmake; Tom Smith πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 172 KB πŸ‘ 2 views

Background. Osseointegrated implants allow patients with oromandibular defects to obtain complete or partial dentition via implant-assisted or implant-borne prostheses. Implants restore masticatory and occlusal function, improving oral intake and articulation. However, use of implants in head and ne

Prioritizing treatment outcomes: Head an
Prioritizing treatment outcomes: Head and neck cancer patients versus nonpatients
✍ Marcy A. List; Judith Lee Rutherford; John Stracks; Barbara Roa Pauloski; Jerily πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 96 KB πŸ‘ 1 views

## Abstract ## Background. Treatment decisions in head and neck cancer (HNC) might involve consideration of uncertain tradeoffs of one late effect against another or increasing toxicity or residual impairment for increased chance of survival. Understanding how patients prioritize potential outcome